Bank Pictet & Cie (Europe)’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,962
Closed -$485K 251
2023
Q4
$485K Buy
33,962
+1,435
+4% +$20.4K 0.01% 189
2023
Q3
$453K Hold
32,527
0.02% 176
2023
Q2
$383K Buy
+32,527
New +$370K 0.01% 202

Other funds holding SBRA

Bank Pictet & Cie (Europe)'s SBRA Position: Q1 2024 in Review

Bank Pictet & Cie (Europe) sold out of Sabra Healthcare REIT (SBRA) in Q1 2024, closing a stake of 33,962 shares — an estimated $485K sold.

Bank Pictet & Cie (Europe) first reported a position in SBRA in Q2 2023 and held it in 3 quarters. The position peaked at $485K in Q4 2023. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Sabra Healthcare REIT position as of Q1 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 33,962 Sabra Healthcare REIT shares in Q1 2024, an estimated $485K.
  • Bank Pictet & Cie (Europe) first reported a position in Sabra Healthcare REIT in Q2 2023 and held it in 3 quarters.
  • Bank Pictet & Cie (Europe)'s Sabra Healthcare REIT position peaked at $485K in Q4 2023.
  • 342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2024, filed 7 May 2024.